PHILADELPHIA and MALVERN, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Carisma Therapeutics Inc. (CARM) (Carisma) and OrthoCellix, Inc. (OrthoCellix), a wholly-owned subsidiary of Ocugen, Inc. (Ocugen), a ...
The posters presented at SITC 2024 will be available online in the "Publications" section of Carisma's website at https://carismatx.com/technology/publications ...
Carisma Therapeutics is a biotechnology Company pioneering macrophage engineering to develop groundbreaking therapies for fibrosis and cancer. With a strong commitment to patient-centric innovation, ...
The posters presented at ASGCT 2024 will be available online in the "Publications" section of Carisma's website at https://carismatx.com/technology/publications ...
PHILADELPHIA and MALVERN, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Carisma Therapeutics Inc. (Nasdaq: CARM) (Carisma) and OrthoCellix, Inc. (OrthoCellix), a wholly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback